Introduction Cancer remains a leading cause of death worldwide. While a curative intent is
the aim of any surgical treatment many patients either present with or go onto develop …

Recently, a series of studies explored the correlation between the neutrophil to lymphocyte
ratio and the prognosis of lung cancer. However, the current opinion regarding the …

Background Recently, more and more studies investigated the association of inflammation
parameters such as the Platelet Lymphocyte Ratio (PLR) and the prognosis of various …

Published data on the prognostic significance of neutrophil-to-lymphocyte ratio (NLR) in non-
small cell lung cancer (NSCLC) are controversial. We performed a meta-analysis to more …

Introduction The hematologic indices of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-
lymphocyte ratio (PLR) are correlated with clinical outcomes after stereotactic radiation …

Background The risk factors for immune-related adverse events (irAEs) remain undefined.
Recently, a correlation between irAEs and clinical benefit was suggested. We examined the …

Abstract Neutrophil to Lymphocyte Ratio (NLR) was recently demonstrated as a useful index
in predicting the prognosis of Non-Small Cell Lung Cancer (NSCLC). Thus, a meta-analysis …

Platelet to lymphocyte ratio (PLR) was recently reported as a useful index in predicting the
prognosis of lung cancer. However, the prognostic role of PLR in lung cancer remains …

Current evidence suggests that the neutrophil‑to‑lymphocyte ratio (NLR) may be a
biomarker for poor prognosis in lung cancer, although this association remains …

Background: Lung cancer (LC) is still the primary cause of cancer deaths worldwide, and
late diagnosis is a major obstacle to improving lung cancer outcomes. Recently, elevated …